Delivery Order SPE2DB20D2014-SPE2DB25FC73R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,389.36 to AmerisourceBergen Drug Corp on July 18, 2025, for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units. This contract, valued at $3,539.90, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is classified as a child contract and executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,946.15 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This non-competitive, firm fixed-price delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,356.03 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,988,146 units of 0.5% Tetracaine Steri-Unit Solution (4 mL). The contract has an ultimate completion date of March 18, 2024 and a ceiling value of $3,087.08. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,127.68 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a topical anesthetic medication. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,269.50, is for the delivery of Tetracaine 0.5% Steri-Unit Solution, 4 ml. The contract is a firm fixed-price delivery order with a period of performance through May 9, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a $977.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562322788 tetracaine 0.5% steri-unit solution 4ml. The single award was issued against an existing DLA pharmaceuticals contract vehicle and will be performed by Amerisourcebergen at its Conshohocken, Pennsylvania facility through September 28, 2023. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,626.78, is for the provision of 0.5% Tetracaine Steri-Unit Solution in 4 mL vials. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was made by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product, under a firm fixed price delivery order. The award is part of a larger indefinite delivery contract (IDC) with a maximum potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC73RDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,582.65 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution 4ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medical products and pharmaceuticals to support military healthcare systems globally. The parent IDC serves as a flexible contract vehicle enabling the company to fulfill diverse federal medical supply requirements, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/13/25 |